Determination of childhood and adult attention deficit hyperactivity disorder symptoms in male heroin dependent patients and clinical effects

Authors

  • Halil İbrahim Öztürk SANKO Üniversitesi , SANKO Üniversitesi
  • Hatice Yardım Özayhan Beyhekim Eğitim ve Araştırma Hastanesi , Beyhekim Eğitim ve Araştırma Hastanesi
  • Tahsin Etli ,
  • Başak Demirel Beyhekim Eğitim ve Araştırma Hastanesi , Beyhekim Eğitim ve Araştırma Hastanesi
  • İbrahim Eren Süleyman Demirel University image/svg+xml

DOI:

https://doi.org/10.51982/bagimli.1142422

Keywords:

Attention deficit hyperactivity disorder, heroin dependence, quality of life

Abstract

Objective: We aimed to determine the frequency and clinical effects of childhood and adulthood attention deficit hyperactivity disorder (ADHD) in male heroin-dependent patients, and to evaluate the clinical conditions that may affect the severity of addiction such as aggression, impulsivity, childhood traumas, anxiety sensitivity, anxiety and depression symptoms.
Method: The study was completed with 100 consecutive male volunteers with heroin dependence, who were in the buprenorphine/naloxone stabilization treatment period. Sociodemografic form, Addiction Severtiy Index (ASI), Wender-Utah Rating Scale (WURS), Adult ADHD Self-Report Scale (ASRS), Barratt Impulsiveness Scale, Version 11 (BIS-11), Diagnostic Interview for ADHD in Adults-2.0 Turkish version (DIVA 2.0-Turksih) , Childhood Trauma Questionnare (CTQ) , Buss-Perry Agression Questionnare (BPAQ), Anxiety Sensitivity Index-3 (ASI-3), Medical Outcomes Study Short Form-36 (SF-36) Health Survey Questionnare, Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety Rating Scale (HARS) were administered to the participants.
Results: A history of childhood ADHD was found in 30% and a diagnosis of adult ADHD was found in 14% of the participants who were administered the DIVA 2.0-Turkish. While the non-ADHD group had higher scores in the SF-36 social function and mental health domains (48.21±24.56, 52.15±19.05, respectively), had lower scores in the ASI legal and psychiatric status domains (4.69±1.75, 3.11±1.16, respectively). In the regression analysis, total score of the BPAQ was found to be an important variable that affecting four of the six ASI dimensions (employment/support status, legal status, drug use and psychiatric status).
Conclusion: ADHD should be carefully evaluated in heroin-dependent patients. In the treatment of heroin addiction, which is a multidimensional disorder, it would be benefical to specifically address aggression.

References

Cadet JL, Jayanthi S. Epigenetics of addiction. Neurochem Int 2021; 147: 105069.

Dydyk AM, Jain NK, Gupta M. Opioid use disorder. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

Cheron J, Kerchove d'Exaerde A. Drug addiction: from bench to bedside. Transl Psychiatry 2021; 11(1): 424.

van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, et al. The international ADHD in substance use disorders prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res 2013; 22(3): 232-244.

Icick R, Moggi F, Slobodin O, et al. Attention deficit/hyperactivity disorder and global severity profiles in treatment seeking patients with substance use disorders. Eur Addict Res 2020; 26(4-5): 201-210.

Estévez N, Dey M, Eich-Höchli D, et al. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men. Epidemiol Psychiatr Sci 2016; 25(3): 255-266.

Fayyad J, Sampson NA, Hwang I, et al. The descriptive epidemiology of DSM-IV adult ADHD in the world health organization world mental health surveys. Atten Defic Hyperact Disord 2017; 9(1): 47-65.

van der Burg D, Crunelle CL, Matthys F, van den Brink W. Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications. Curr Opin Psychiatry 2019; 32(4): 300-306.

Coppola M, Sacchetto G, Mondola R. Craving for heroin: difference between methadone maintenance therapy patients with and without ADHD. Trends Psychiatry Psychother 2019; 41(1): 83-86.

Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? findings from a sample of adults with and without ADHD. Am J Addict 1998; 7(2): 156-163.

Wickens CM, Kao A, Ialomiteanu AR, et al. Conduct disorder and attention-deficit/hyperactivity disorder as risk factors for prescription opioid use. Drug Alcohol Depend 2020; 213: 108103.

Carpentier PJ, van Gogh MT, Knapen LJ, et al. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 2011; 17(1): 10-20.

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39(2): 175-191.

McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9(3):199-213.

Demirbaş H, Ilhan Özgür İ, Doğan YB, Canatan A. Reliability and validity of the Turkish version of the addiction severity index in male alcohol dependents. Noro Psikiyatr Ars 2014; 51(3): 216-221.

Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150(6): 885-890.

Öncü B, Ölmez Ş, Şentürk V. Wender-Utah derecelendirme ölçeği Türkçe formunun erişkin dikkat eksikliği ve hiperaktivite bozukluğu’nda geçerlik ve güvenilirlik çalışması. Türk Psikiyatri Dergisi 2005; 16(4): 252-259.

Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005; 35(2): 245-256.

Doğan S, Öncü B, Varol Saraçoğlu G, Küçükgöncü S. Erişkin dikkat eksikliği hiperaktivite bozukluğu kendi bildirim ölçeği (ASRS-v1.1): Türkçe formunun geçerlilik ve güvenilirliği. Anadolu Psikiyatri Dergisi 2009; 10(2): 77-87.

Kooij JJS, Francken MH. Yetişkinlerde DEHB için Tanısal Görüşme DIVA-2.0. Motavallı Mukaddes N, Öncü B, Bron A, et al. (Çevirenler). http://www.divacenter.eu/Content/VertalingPDFs/DIVA_2_Turks.pdf (04 Aralık 2013’te ulaşıldı).

Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995; 51(6): 768-774.

Güleç H, Tamam L, Yazıcı Güleç M, et al. Psychometric properties of the Turkish version of the Barratt impulsiveness scale-11. Bulletin of Clinical Psychopharmacology 2008; 18(4): 251-258.

Bernstein DP, Stein JA, Newcomb MD, et al. Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl 2003; 27(2): 169-190.

Şar V, Öztürk E, İkikardeş E. Çocukluk çağı ruhsal travma ölçeğinin Türkçe uyarlamasının geçerlilik ve güvenirliği. Turkiye Klinikleri J Med Sci 2012; 32(4): 1054-1063.

Buss AH, Perry M. The aggression questionnaire. J Pers Soc Psychol 1992; 63(3): 452-459.

Evren C, Çınar Ö, Güleç H, Çelik S, et al. The validity and reliability of the Turkish version of the Buss-Perry’s aggression questionnaire in male substance dependent inpatients. Düşünen Adam: The Journal of Psychiatry and Neurological Sciences 2011; 24(4): 283-295.

Taylor S, Zvolensky MJ, Cox BJ, et al. Robust dimensions of anxiety sensitivity: development and initial validation of the anxiety sensitivity index-3. Psychol Assess 2007; 19(2): 176-188.

Mantar A, Yemez B, Alkın T. Anksiyete duyarlılığı indeksi-3’ün Türkçe formunun geçerlik ve güvenilirlik çalışması. Türk Psikiyatri Dergisi 2010; 21(3): 225-234.

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 1992; 30(6): 473-483.

Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A. Kısa form 36 (KF–36)’nın Türkçe versiyonunun güvenilirliği ve geçerliliği. İlaç ve Tedavi Dergisi 1999; 12(2): 102-106.

Aydemir Ö, Köroğlu E (editörler). Kısa form (KF-36). Psikiyatride Kullanılan Klinik Ölçekler. 7. Baskı, Ankara: HYB Basım Yayın, 2014: 432-439.

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23(1): 56-62.

Akdemir A, Örsel S, Dağ İ, et al. Hamilton depresyon derecelendirme ölçeği (HDDÖ)’nin geçerliği, güvenirliği ve klinikte kullanımı. Psikiyatri Psikoloji Psikofarmakoloji Dergisi 1996; 4(4): 251-259.

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32(1): 50-55.

Yazıcı MK, Demir B, Tanriverdi N. Hamilton anksiyete değerlendirme ölçeği, değerlendiriciler arası güvenirlik ve geçerlik çalısması. Türk Psikiyatri Dergisi 1998; 9(2): 114-117.

Gupta S, Bhatia G, Sarkar S, et al. Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence: an exploratory study. Indian J Psychiatry 2020; 62(5): 501-508.

Lugoboni F, Levin FR, Pieri MC, et al. Co-occurring attention deficit hyperactivity disorder symptoms in adults affected by heroin dependence: patients characteristics and treatment needs. Psychiatry Res 2017; 250: 210216.

Moura HF, Faller S, Benzano D, et al. The effects of ADHD in adult substance abusers. J Addict Dis. 2013; 32(3): 252-262.

Daigre C, Roncero C, Grau-López L, et al. Attention deficit hyperactivity disorder in cocaine-dependent adults: a psychiatric comorbidity analysis. Am J Addict 2013; 22(5): 466-473.

Quintero J, Morales I, Vera R, et al. The impact of adult ADHD in the quality of life profile. J Atten Disord 2019; 23(9): 1007-1016.

Zhang SY, Qiu SW, Pan MR, et al. Adult ADHD, executive function, depressive/anxiety symptoms, and quality of life: A serial two-mediator model. J Affect Disord 2021; 293: 97-108.

Feelemyer JP, Jarlais DCD, Arasteh K, et al. Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review. Drug Alcohol Depend 2014; 134(1): 251-258.

Flores-García L, Lensing MB, Ytterstad E, Eisemann M. Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study. Atten Defic Hyperact Disord 2019; 11(3): 299-310.

Buckingham ET, Daniolos P. Longitudinal outcomes for victims of child abuse. Curr Psychiatry Rep 2013; 15(2): 342.

Zoroğlu S, Tüzün Ü, Şar V, et al. Çocukluk dönemi istismar ve ihmalinin olası sonuçları. Anadolu Psikiyatri Dergisi 2001; 2(2): 69-78.

Rucklidge JJ, Brown DL, Crawford S, Kaplan BJ. Retrospective reports of childhood trauma in adults with ADHD. J Atten Disord 2006; 9(4): 631-641.

De Sanctis VA, Trampush JW, Harty SC, et al. Childhood maltreatment and conduct disorder: independent predictors of adolescent substance use disorders in youth with attention deficit/hyperactivity disorder. J Clin Child Adolesc Psychol 2008; 37(4): 785-793.

Kokko K, Pulkkinen L. Aggression in childhood and long-term unemployment in adulthood: a cycle of maladaptation and some protective factors. Developmental psychology 2000; 36(4): 463-472.

Fatséas M, Hurmic H, Serre F, et al. Addiction severity pattern associated with adult and childhood attention deficit hyperactivity disorder (ADHD) in patients with addictions. Psychiatry Res 2016; 246: 656-662.

Stathopoulou G, Gold AK, Hoyt DL, et al. Does anxiety sensitivity predict addiction severity in opioid use disorder? Addict Behav 2021; 112: 106644.

Algül A, Semiz ÜB, Ateş MA, et al. Relationship of substance use disorder to aggression in male subjects with antisocial personality disorder. Düşünen Adam: The Journal of Psychiatry and Neurological Sciences 2007; 20(3): 141-150.

Coccaro EF, Fridberg DJ, Fanning JR, et al. Substance use disorders: relationship with intermittent explosive disorder and with aggression, anger, and impulsivity. J Psychiatr Res 2016; 81: 127-132.

Karadağ F, Uluğ B. Madde kullanım bozukluklarında ek tanı. Evren C, Ögel K, Uluğ B (editörler). Alkol Madde Bağımlılığı Tanı ve Tedavi El Kitabı. 1. Baskı, Ankara: Türkiye Psikiyatri Derneği Yayınları, 2012: 151-172.

Yargıç İ, Vardar E. Alkol ve madde kullanım bozukluklarında komorbidite. Psikiyatride Güncel 2014; 4(2): 140150.

Assari S, Bazargan M. Marital status and physical health: racial differences. Int J Epidemiol Res 2019; 6(3): 108113.

Kim A, Lee JA, Park HS. Health behaviors and illness according to marital status in middle-aged Koreans. J Public Health (Oxf). 2018; 40(2): e99-e106.

Kojima G, Walters K, Iliffe S, et al. Marital status and risk of physical frailty: a systematic review and meta-analysis. J Am Med Dir Assoc 2020; 21(3): 322-330.

Downloads

Published

2023-09-01

Issue

Section

Research Article